跨性别护理、科学和权利的全球倒退

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-07-01 DOI:10.1038/s41591-025-03805-5

Igor Longobardi, Bruna Caruso Mazzolani, Hamilton Roschel, Bruno Gualano, Alexandre Saadeh

{"title":"跨性别护理、科学和权利的全球倒退","authors":"Igor Longobardi, Bruna Caruso Mazzolani, Hamilton Roschel, Bruno Gualano, Alexandre Saadeh","doi":"10.1038/s41591-025-03805-5","DOIUrl":null,"url":null,"abstract":"Gender-affirming care for transgender youth is under attack. From Europe to the Americas, governments and professional bodies have imposed sweeping restrictions on essential medical interventions, bypassing scientific and ethical standards. Although framed as protective or cautious, these policies are neither: they misrepresent evidence, disregard international clinical guidelines, and expose vulnerable populations to harm.This rollback is not isolated. In 2024–2025, the UK, USA and Brazil — three of the world’s largest democracies — enacted or reinforced limits on gender-affirming care. Despite differing sociopolitical contexts, they share key features: selective use of scientific uncertainty, erosion of clinical autonomy, and marginalization of trans voices in policymaking.","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"32 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The global rollback of transgender care, science and rights\",\"authors\":\"Igor Longobardi, Bruna Caruso Mazzolani, Hamilton Roschel, Bruno Gualano, Alexandre Saadeh\",\"doi\":\"10.1038/s41591-025-03805-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gender-affirming care for transgender youth is under attack. From Europe to the Americas, governments and professional bodies have imposed sweeping restrictions on essential medical interventions, bypassing scientific and ethical standards. Although framed as protective or cautious, these policies are neither: they misrepresent evidence, disregard international clinical guidelines, and expose vulnerable populations to harm.This rollback is not isolated. In 2024–2025, the UK, USA and Brazil — three of the world’s largest democracies — enacted or reinforced limits on gender-affirming care. Despite differing sociopolitical contexts, they share key features: selective use of scientific uncertainty, erosion of clinical autonomy, and marginalization of trans voices in policymaking.\",\"PeriodicalId\":19037,\"journal\":{\"name\":\"Nature Medicine\",\"volume\":\"32 1\",\"pages\":\"\"},\"PeriodicalIF\":58.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41591-025-03805-5\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03805-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

针对跨性别青年的性别肯定护理受到攻击。从欧洲到美洲，各国政府和专业机构绕过科学和道德标准，对基本医疗干预措施实施了广泛的限制。尽管这些政策被描述为保护或谨慎，但两者都不是：它们歪曲证据，无视国际临床指南，并使弱势群体受到伤害。此回滚不是孤立的。在2024-2025年，英国、美国和巴西这三个世界上最大的民主国家颁布或加强了对性别确认护理的限制。尽管社会政治背景不同，但它们有一些共同的关键特征：选择性地使用科学的不确定性，侵蚀临床自主权，以及在政策制定中边缘化跨性别者的声音。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The global rollback of transgender care, science and rights

Gender-affirming care for transgender youth is under attack. From Europe to the Americas, governments and professional bodies have imposed sweeping restrictions on essential medical interventions, bypassing scientific and ethical standards. Although framed as protective or cautious, these policies are neither: they misrepresent evidence, disregard international clinical guidelines, and expose vulnerable populations to harm.

This rollback is not isolated. In 2024–2025, the UK, USA and Brazil — three of the world’s largest democracies — enacted or reinforced limits on gender-affirming care. Despite differing sociopolitical contexts, they share key features: selective use of scientific uncertainty, erosion of clinical autonomy, and marginalization of trans voices in policymaking.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.